{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T06:04:02Z","timestamp":1792649042002,"version":"4.5.0"},"reference-count":91,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T00:00:00Z","timestamp":1676332800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100008478","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008478","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["RO1 AI059457"],"award-info":[{"award-number":["RO1 AI059457"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["U19 AI128741"],"award-info":[{"award-number":["U19 AI128741"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["HHSN272201300010C"],"award-info":[{"award-number":["HHSN272201300010C"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["UM1 AI124377"],"award-info":[{"award-number":["UM1 AI124377"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["PO1 AI174856"],"award-info":[{"award-number":["PO1 AI174856"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["P51 OD011092-61"],"award-info":[{"award-number":["P51 OD011092-61"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["OPP1107409"],"award-info":[{"award-number":["OPP1107409"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006668","name":"Oregon Health and Science University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006668","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019650","name":"Vir Biotechnology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019650","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Immunology"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.it.2023.02.001","type":"journal-article","created":{"date-parts":[[2023,3,7]],"date-time":"2023-03-07T08:47:15Z","timestamp":1678178835000},"page":"287-304","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":50,"title":["Programming cytomegalovirus as an HIV vaccine"],"prefix":"10.1016","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0546-398X","authenticated-orcid":false,"given":"Louis J.","family":"Picker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey D.","family":"Lifson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr","given":"Michael","family":"Gale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott G.","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus","family":"Fr\u00fch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.it.2023.02.001_bb0005","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/j.1600-065X.1999.tb01283.x","article-title":"HIV's evasion of the cellular immune response","volume":"168","author":"Collins","year":"1999","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.it.2023.02.001_bb0010","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1038\/88656","article-title":"Immune control of HIV: the obstacles of HLA and viral diversity","volume":"2","author":"Walker","year":"2001","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.it.2023.02.001_bb0015","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.chom.2010.06.004","article-title":"Immune evasion and counteraction of restriction factors by HIV-1 and other primate lentiviruses","volume":"8","author":"Kirchhoff","year":"2010","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.it.2023.02.001_bb0020","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1146\/annurev-med-042010-085643","article-title":"New paradigms for HIV\/AIDS vaccine development","volume":"63","author":"Picker","year":"2012","journal-title":"Ann. Rev. Med."},{"key":"10.1016\/j.it.2023.02.001_bb0025","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/j.jmb.2013.12.003","article-title":"Innate antiviral immune signaling, viral evasion and modulation by HIV-1","volume":"426","author":"Rustagi","year":"2014","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.it.2023.02.001_bb0030","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.sbi.2015.04.004","article-title":"HIV suppression by host restriction factors and viral immune evasion","volume":"31","author":"Jia","year":"2015","journal-title":"Curr. Opin. Struct. Biol."},{"key":"10.1016\/j.it.2023.02.001_bb0035","doi-asserted-by":"crossref","first-page":"2354","DOI":"10.1126\/science.1070441","article-title":"Diversity considerations in HIV-1 vaccine selection","volume":"296","author":"Gaschen","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.it.2023.02.001_bb0040","doi-asserted-by":"crossref","first-page":"9228","DOI":"10.1128\/JVI.79.14.9228-9235.2005","article-title":"CD8+ T-lymphocyte response to major immunodominant epitopes after vaginal exposure to simian immunodeficiency virus: too late and too little","volume":"79","author":"Reynolds","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.it.2023.02.001_bb0045","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1008121","article-title":"ALVAC-HIV B\/C candidate HIV vaccine efficacy dependent on neutralization profile of challenge virus and adjuvant dose and type","volume":"15","author":"Schifanella","year":"2019","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.it.2023.02.001_bb0050","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1126\/science.aab3886","article-title":"Protective efficacy of adenovirus\/protein vaccines against SIV challenges in rhesus monkeys","volume":"349","author":"Barouch","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.it.2023.02.001_bb0055","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1056\/NEJMoa0908492","article-title":"Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand","volume":"361","author":"Rerks-Ngarm","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.it.2023.02.001_bb0060","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1056\/NEJMoa2031499","article-title":"Vaccine efficacy of ALVAC-HIV and bivalent subtype C gp120-MF59 in adults","volume":"384","author":"Gray","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.it.2023.02.001_bb0065","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1056\/NEJMoa2031738","article-title":"Two randomized trials of neutralizing antibodies to prevent HIV-1 acquisition","volume":"384","author":"Corey","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.it.2023.02.001_bb0070","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1080\/14760584.2019.1690458","article-title":"Strategies for inducing effective neutralizing antibody responses against HIV-1","volume":"18","author":"Del Moral-Sanchez","year":"2019","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.it.2023.02.001_bb0075","doi-asserted-by":"crossref","first-page":"5811","DOI":"10.4049\/jimmunol.1102695","article-title":"Hidden memories: frontline memory T cells and early pathogen interception","volume":"188","author":"Masopust","year":"2012","journal-title":"J. Immunol."},{"key":"10.1016\/j.it.2023.02.001_bb0080","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1038\/nri.2016.38","article-title":"T cell responses to cytomegalovirus","volume":"16","author":"Klenerman","year":"2016","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.it.2023.02.001_bb0085","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1084\/jem.20050882","article-title":"Broadly targeted human cytomegalovirus-specific CD4+ and CD8+ T cells dominate the memory compartments of exposed subjects","volume":"202","author":"Sylwester","year":"2005","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.it.2023.02.001_bb0090","doi-asserted-by":"crossref","first-page":"2908","DOI":"10.1002\/(SICI)1521-4141(199909)29:09<2908::AID-IMMU2908>3.0.CO;2-8","article-title":"Distribution of human CMV-specific memory T cells among the CD8pos. subsets defined by CD57, CD27, and CD45 isoforms","volume":"29","author":"Kern","year":"1999","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.it.2023.02.001_bb0095","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.4049\/jimmunol.1100560","article-title":"Cytomegalovirus-specific T cell immunity is maintained in immunosenescent rhesus macaques","volume":"187","author":"Cicin-Sain","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.it.2023.02.001_bb0100","series-title":"Cytomegaloviruses: From Molecular Pathogenesis to Intervention","article-title":"Vaccine vectors using the unique biology and immunology of cytomegalovirus","author":"Jarvis","year":"2013"},{"key":"10.1016\/j.it.2023.02.001_bb0105","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0065-3527(08)00405-3","article-title":"Rhesus cytomegalovirus a nonhuman primate model for the study of human cytomegalovirus","volume":"72","author":"Yue","year":"2008","journal-title":"Adv. Virus Res."},{"key":"10.1016\/j.it.2023.02.001_bb0110","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s00430-007-0073-y","article-title":"Rhesus CMV: an emerging animal model for human CMV","volume":"197","author":"Powers","year":"2008","journal-title":"Med. Microbiol. Immunol."},{"key":"10.1016\/j.it.2023.02.001_bb0115","doi-asserted-by":"crossref","first-page":"8959","DOI":"10.1128\/JVI.01132-12","article-title":"Reevaluation of the coding potential and proteomic analysis of the BAC-derived rhesus cytomegalovirus strain 68-1","volume":"86","author":"Malouli","year":"2012","journal-title":"J. Virol."},{"key":"10.1016\/j.it.2023.02.001_bb0120","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1097\/COH.0000000000000311","article-title":"Nonhuman primate models for the evaluation of HIV-1 preventive vaccine strategies: model parameter considerations and consequences","volume":"11","author":"Del Prete","year":"2016","journal-title":"Curr. Opin. HIV AIDS"},{"key":"10.1016\/j.it.2023.02.001_bb0125","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/978-981-13-0484-2_5","article-title":"Monkey models and HIV vaccine research","volume":"1075","author":"Chen","year":"2018","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.it.2023.02.001_bb0130","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/nm.1935","article-title":"Effector memory T cell responses are associated with protection of rhesus monkeys from mucosal simian immunodeficiency virus challenge","volume":"15","author":"Hansen","year":"2009","journal-title":"Nat. Med."},{"key":"10.1016\/j.it.2023.02.001_bb0135","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/nature10003","article-title":"Profound early control of highly pathogenic SIV by an effector memory T-cell vaccine","volume":"473","author":"Hansen","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.it.2023.02.001_bb0140","doi-asserted-by":"crossref","DOI":"10.1002\/rmv.2034","article-title":"Estimation of the worldwide seroprevalence of cytomegalovirus: a systematic review and meta-analysis","volume":"29","author":"Zuhair","year":"2019","journal-title":"Rev. Med. Virol."},{"key":"10.1016\/j.it.2023.02.001_bb0145","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/nature12519","article-title":"Immune clearance of highly pathogenic SIV infection","volume":"502","author":"Hansen","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.it.2023.02.001_bb0150","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.164692","article-title":"Late gene expression-deficient cytomegalovirus vectors elicit conventional T cells that do not protect against SIV","author":"Hansen","year":"2023","journal-title":"JCI Insight"},{"key":"10.1016\/j.it.2023.02.001_bb0155","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaw2607","article-title":"A live-attenuated RhCMV\/SIV vaccine shows long-term efficacy against heterologous SIV challenge","volume":"11","author":"Hansen","year":"2019","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.it.2023.02.001_bb0160","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abg5413","article-title":"Cytomegaloviral determinants of CD8+ T cell programming and RhCMV\/SIV vaccine efficacy","volume":"6","author":"Malouli","year":"2021","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.it.2023.02.001_bb0165","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abn9301","article-title":"Myeloid cell tropism enables MHC-E-restricted CD8+ T cell priming and vaccine efficacy by the RhCMV\/SIV vaccine","volume":"7","author":"Hansen","year":"2022","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.it.2023.02.001_bb0170","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaw2603","article-title":"Enhancing safety of cytomegalovirus-based vaccine vectors by engaging host intrinsic immunity","volume":"11","author":"Marshall","year":"2019","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.it.2023.02.001_bb0175","doi-asserted-by":"crossref","DOI":"10.1126\/science.1237874","article-title":"Cytomegalovirus vectors violate CD8+ T cell epitope recognition paradigms","volume":"340","author":"Hansen","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.it.2023.02.001_bb0180","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1126\/science.aac9475","article-title":"Broadly targeted CD8+ T cell responses restricted by major histocompatibility complex E","volume":"351","author":"Hansen","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.it.2023.02.001_bb0185","doi-asserted-by":"crossref","DOI":"10.1126\/science.abe9233","article-title":"Modulation of MHC-E transport by viral decoy ligands is required for RhCMV\/SIV vaccine efficacy","volume":"372","author":"Verweij","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.it.2023.02.001_bb0190","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1126\/science.287.5455.1031","article-title":"Surface expression of HLA-E, an inhibitor of natural killer cells, enhanced by human cytomegalovirus gpUL40","volume":"287","author":"Tomasec","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.it.2023.02.001_bb0195","doi-asserted-by":"crossref","first-page":"7570","DOI":"10.1073\/pnas.112680099","article-title":"UL40-mediated NK evasion during productive infection with human cytomegalovirus","volume":"99","author":"Wang","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.it.2023.02.001_bb0200","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.coi.2017.04.009","article-title":"Unusual antigen presentation offers new insight into HIV vaccine design","volume":"46","author":"McMichael","year":"2017","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.it.2023.02.001_bb0205","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1126\/science.1185350","article-title":"Evasion of CD8+ T cells is critical for superinfection by cytomegalovirus","volume":"328","author":"Hansen","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.it.2023.02.001_bb0210","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1005868","article-title":"Natural killer cell evasion is essential for infection by rhesus cytomegalovirus","volume":"12","author":"Sturgill","year":"2016","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.it.2023.02.001_bb0215","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.chom.2008.08.003","article-title":"Harnessing endogenous miRNAs to control virus tissue tropism as a strategy for developing attenuated virus vaccines","volume":"4","author":"Barnes","year":"2008","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.it.2023.02.001_bb0220","doi-asserted-by":"crossref","first-page":"2767","DOI":"10.4049\/jimmunol.1200966","article-title":"Priming of CD8+ T cells against cytomegalovirus-encoded antigens is dominated by cross-presentation","volume":"190","author":"Busche","year":"2013","journal-title":"J. Immunol."},{"key":"10.1016\/j.it.2023.02.001_bb0225","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1009278","article-title":"Interleukin-15 response signature predicts RhCMV\/SIV vaccine efficacy","volume":"17","author":"Barrenas","year":"2021","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.it.2023.02.001_bb0230","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1038\/nri3919","article-title":"IL-15 functions as a danger signal to regulate tissue-resident T cells and tissue destruction","volume":"15","author":"Jabri","year":"2015","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.it.2023.02.001_bb0235","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1172\/JCI27564","article-title":"IL-15 induces CD4 effector memory T cell production and tissue emigration in nonhuman primates","volume":"116","author":"Picker","year":"2006","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.it.2023.02.001_bb0240","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.cytogfr.2017.08.002","article-title":"Immunobiology of the IL-15\/IL-15Ralpha complex as an antitumor and antiviral agent","volume":"38","author":"Guo","year":"2017","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.it.2023.02.001_bb0245","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.cyto.2012.05.020","article-title":"Functions of IL-15 in anti-viral immunity: multiplicity and variety","volume":"59","author":"Verbist","year":"2012","journal-title":"Cytokine"},{"key":"10.1016\/j.it.2023.02.001_bb0250","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20191062","article-title":"Interleukin-15 (dys)regulation of lymphoid homeostasis: Implications for therapy of autoimmunity and cancer","volume":"217","author":"Waldmann","year":"2020","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.it.2023.02.001_bb0255","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.4049\/jimmunol.1600065","article-title":"Effect of anti-IL-15 administration on T cell and NK cell homeostasis in rhesus macaques","volume":"197","author":"DeGottardi","year":"2016","journal-title":"J. Immunol."},{"key":"10.1016\/j.it.2023.02.001_bb0260","doi-asserted-by":"crossref","first-page":"2590","DOI":"10.3389\/fimmu.2019.02590","article-title":"JAK\/STAT cytokine signaling at the crossroad of NK cell development and maturation","volume":"10","author":"Gotthardt","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.it.2023.02.001_bb0265","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1038\/nri1706","article-title":"Perils at mucosal front lines for HIV and SIV and their hosts","volume":"5","author":"Haase","year":"2005","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.it.2023.02.001_bb0270","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/j.1600-065X.1999.tb01282.x","article-title":"The downregulation of CD4 and MHC-I by primate lentiviruses: a paradigm for the modulation of cell surface receptors","volume":"168","author":"Piguet","year":"1999","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.it.2023.02.001_bb0275","doi-asserted-by":"crossref","first-page":"49","DOI":"10.4049\/jimmunol.1700841","article-title":"The role of MHC-E in T cell immunity is conserved among humans, rhesus macaques, and cynomolgus macaques","volume":"200","author":"Wu","year":"2018","journal-title":"J. Immunol."},{"key":"10.1016\/j.it.2023.02.001_bb0280","doi-asserted-by":"crossref","first-page":"3137","DOI":"10.1038\/s41467-018-05459-z","article-title":"Pathogen-derived HLA-E bound epitopes reveal broad primary anchor pocket tolerability and conformationally malleable peptide binding","volume":"9","author":"Walters","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.it.2023.02.001_bb0285","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1002\/eji.202048719","article-title":"Detailed and atypical HLA-E peptide binding motifs revealed by a novel peptide exchange binding assay","volume":"50","author":"Walters","year":"2020","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.it.2023.02.001_bb0290","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.110959","article-title":"Primary and secondary functions of HLA-E are determined by stability and conformation of the peptide-bound complexes","volume":"39","author":"Walters","year":"2022","journal-title":"Cell Rep."},{"key":"10.1016\/j.it.2023.02.001_bb0295","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abg1703","article-title":"HLA-E-restricted, Gag-specific CD8+ T cells can suppress HIV-1 infection, offering vaccine opportunities","volume":"6","author":"Yang","year":"2021","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.it.2023.02.001_bb0300","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1000646","article-title":"Autocrine production of beta-chemokines protects CMV-specific CD4 T cells from HIV infection","volume":"5","author":"Casazza","year":"2009","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.it.2023.02.001_bb0305","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006014","article-title":"Cross-species rhesus cytomegalovirus infection of cynomolgus macaques","volume":"12","author":"Burwitz","year":"2016","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.it.2023.02.001_bb0310","doi-asserted-by":"crossref","first-page":"19236","DOI":"10.1038\/s41598-019-55508-w","article-title":"Characterization of a live-attenuated HCMV-based vaccine platform","volume":"9","author":"Caposio","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.it.2023.02.001_bb0315","doi-asserted-by":"crossref","DOI":"10.1155\/2010\/907092","article-title":"The emerging role of HLA-E-restricted CD8+ T lymphocytes in the adaptive immune response to pathogens and tumors","volume":"2010","author":"Pietra","year":"2010","journal-title":"J. Biomed. Biotechnol."},{"key":"10.1016\/j.it.2023.02.001_bb0320","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/j.chom.2022.07.013","article-title":"Cytomegalovirus-vaccine-induced unconventional T cell priming and control of SIV replication is conserved between primate species","volume":"30","author":"Malouli","year":"2022","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.it.2023.02.001_bb0325","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S1074-7613(00)80529-4","article-title":"A novel immunoglobulin superfamily receptor for cellular and viral MHC class I molecules","volume":"7","author":"Cosman","year":"1997","journal-title":"Immunity"},{"key":"10.1016\/j.it.2023.02.001_bb0330","doi-asserted-by":"crossref","first-page":"10095","DOI":"10.1073\/pnas.0804551105","article-title":"Structure of UL18, a peptide-binding viral MHC mimic, bound to a host inhibitory receptor","volume":"105","author":"Yang","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.it.2023.02.001_bb0335","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00719-19","article-title":"Primary HIV-1 strains use nef to downmodulate HLA-E surface expression","volume":"93","author":"van Stigt Thans","year":"2019","journal-title":"J. Virol."},{"key":"10.1016\/j.it.2023.02.001_bb0340","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.coi.2017.06.010","article-title":"CD8+ T cell programming by cytomegalovirus vectors: applications in prophylactic and therapeutic vaccination","volume":"47","author":"Fruh","year":"2017","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.it.2023.02.001_bb0345","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.4049\/jimmunol.1900795","article-title":"MHC-E-restricted CD8+ T cells target hepatitis B virus-infected human hepatocytes","volume":"204","author":"Burwitz","year":"2020","journal-title":"J. Immunol."},{"key":"10.1016\/j.it.2023.02.001_bb0350","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/2695396","article-title":"Characteristics of HLA-E restricted T-cell responses and their role in infectious diseases","volume":"2016","author":"Joosten","year":"2016","journal-title":"J. Immunol. Res."},{"key":"10.1016\/j.it.2023.02.001_bb0355","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1126\/science.1217550","article-title":"Natural SIV hosts: showing AIDS the door","volume":"335","author":"Chahroudi","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.it.2023.02.001_bb0360","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1146\/annurev-immunol-041015-055515","article-title":"Broadly neutralizing antibodies to HIV and their role in vaccine design","volume":"34","author":"Burton","year":"2016","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.it.2023.02.001_bb0365","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/nm.3781","article-title":"B cell follicle sanctuary permits persistent productive simian immunodeficiency virus infection in elite controllers","volume":"21","author":"Fukazawa","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.it.2023.02.001_bb0370","doi-asserted-by":"crossref","first-page":"269","DOI":"10.3390\/v11030269","article-title":"Cat and mouse: HIV transcription in latency, immune evasion and cure\/remission strategies","volume":"11","author":"Delannoy","year":"2019","journal-title":"Viruses"},{"key":"10.1016\/j.it.2023.02.001_bb0375","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1126\/science.aav5095","article-title":"Structural topology defines protective CD8+ T cell epitopes in the HIV proteome","volume":"364","author":"Gaiha","year":"2019","journal-title":"Science"},{"key":"10.1016\/j.it.2023.02.001_bb0380","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1084\/jem.20070567","article-title":"Progressive CD4+ central memory T cell decline results in CD4+ effector memory insufficiency and overt disease in chronic SIV infection","volume":"204","author":"Okoye","year":"2007","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.it.2023.02.001_bb0385","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/imr.12066","article-title":"CD4+ T-cell depletion in HIV infection: mechanisms of immunological failure","volume":"254","author":"Okoye","year":"2013","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.it.2023.02.001_bb0390","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1038\/s41577-020-0274-9","article-title":"CD8+ T cells in HIV control, cure and prevention","volume":"20","author":"Collins","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.it.2023.02.001_bb0395","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1097\/COH.0b013e3283453e16","article-title":"Understanding animal models of elite control: windows on effective immune responses against immunodeficiency viruses","volume":"6","author":"Mudd","year":"2011","journal-title":"Curr. Opin. HIV AIDS"},{"key":"10.1016\/j.it.2023.02.001_bb0400","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1016\/j.immuni.2021.08.007","article-title":"Functional impairment of HIV-specific CD8+ T cells precedes aborted spontaneous control of viremia","volume":"54","author":"Collins","year":"2021","journal-title":"Immunity"},{"key":"10.1016\/j.it.2023.02.001_bb0405","doi-asserted-by":"crossref","first-page":"8827","DOI":"10.1128\/JVI.00895-07","article-title":"Mamu-B*08-positive macaques control simian immunodeficiency virus replication","volume":"81","author":"Loffredo","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.it.2023.02.001_bb0410","doi-asserted-by":"crossref","first-page":"3465","DOI":"10.1128\/JVI.02392-06","article-title":"Subdominant CD8+ T-cell responses are involved in durable control of AIDS virus replication","volume":"81","author":"Friedrich","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.it.2023.02.001_bb0415","doi-asserted-by":"crossref","first-page":"11514","DOI":"10.1128\/JVI.01298-09","article-title":"Infection with \u2018escaped\u2019 virus variants impairs control of simian immunodeficiency virus SIVmac239 replication in Mamu-B*08-positive macaques","volume":"83","author":"Valentine","year":"2009","journal-title":"J. Virol."},{"key":"10.1016\/j.it.2023.02.001_bb0420","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/s41586-020-2651-8","article-title":"Distinct viral reservoirs in individuals with spontaneous control of HIV-1","volume":"585","author":"Jiang","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.it.2023.02.001_bb0425","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abl4097","article-title":"Signatures of immune selection in intact and defective proviruses distinguish HIV-1 elite controllers","volume":"13","author":"Lian","year":"2021","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.it.2023.02.001_bb0430","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1038\/s41591-018-0130-7","article-title":"Early antiretroviral therapy limits SIV reservoir establishment to delay or prevent post-treatment viral rebound","volume":"24","author":"Okoye","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.it.2023.02.001_bb0435","doi-asserted-by":"crossref","first-page":"70","DOI":"10.3390\/vaccines7030070","article-title":"Human cytomegalovirus cell tropism and host cell receptors","volume":"7","author":"Gerna","year":"2019","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.it.2023.02.001_bb0440","first-page":"63","article-title":"Cytomegalovirus cell tropism","volume":"325","author":"Sinzger","year":"2008","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.it.2023.02.001_bb0445","first-page":"333","article-title":"Cytomegalovirus immune evasion","volume":"325","author":"Powers","year":"2008","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.it.2023.02.001_bb0450","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.3389\/fimmu.2019.01155","article-title":"Subversion of immune response by human cytomegalovirus","volume":"10","author":"Patro","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.it.2023.02.001_bb0455","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1038\/35869","article-title":"HLA-E binds to natural killer cell receptors CD94\/NKG2A, B and C","volume":"391","author":"Braud","year":"1998","journal-title":"Nature"}],"container-title":["Trends in Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471490623000261?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471490623000261?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T19:51:20Z","timestamp":1778615480000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1471490623000261"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":91,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["S1471490623000261"],"URL":"https:\/\/doi.org\/10.1016\/j.it.2023.02.001","relation":{},"ISSN":["1471-4906"],"issn-type":[{"value":"1471-4906","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Programming cytomegalovirus as an HIV vaccine","name":"articletitle","label":"Article Title"},{"value":"Trends in Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.it.2023.02.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}